Skip to main content
Smart Investors Daily
Aclarion, Inc. logo

NASDAQ · ACONW

Aclarion, Inc.

Healthcare · Medical - Healthcare Information Services

$0.03

Up+$0.00 (+0.00%)

Updated Sep 13, 2026, 12:14 PM

SID Score

3.1/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
19.95K
P/E ratio
-0.22
Dividend yield
0.00%
52-week range
$0.02 – $0.20
Volume
241
Avg. volume
17.8K

Price performance

ACONW price history

1M range · 15 trading sessions · Daily adjusted prices

ACONW closed at $0.03 after 15 trading sessions, up 3.23% for the selected period.

Last close
$0.03
Period change
+3.23%
Period low
$0.02
Period high
$0.04
Daily close
View OHLC price history
ACONW OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 11, 2026$0.0256$0.0256$0.0256$0.0256241
Sep 9, 2026$0.0256$0.0256$0.0256$0.0256646
Sep 8, 2026$0.0256$0.0256$0.0256$0.02561.36K
Sep 3, 2026$0.0498$0.05$0.0257$0.02585.66K
Sep 2, 2026$0.0317$0.04$0.0317$0.044.09K
Sep 1, 2026$0.0299$0.0308$0.0298$0.03087.94K
Aug 31, 2026$0.03$0.03$0.0254$0.02542.47K
Aug 28, 2026$0.026$0.026$0.0254$0.02553.15K
Aug 27, 2026$0.0255$0.0317$0.0255$0.031713.78K
Aug 26, 2026$0.0257$0.0257$0.0257$0.02571.44K
Aug 25, 2026$0.0256$0.0317$0.0256$0.0317620
Aug 20, 2026$0.03$0.0317$0.03$0.0325.34K
Aug 19, 2026$0.0248$0.0509$0.0248$0.0341K
Aug 18, 2026$0.0248$0.0248$0.0248$0.02481.19K
Aug 17, 2026$0.0248$0.0249$0.0248$0.02485.53K

Latest ACONW news

The latest Smart Investors Daily articles mentioning ACONW.

ACONW research

Overview

Company profile and research snapshot.

Company profile

Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.